Publicación:
Comprehensive virtual screening of 4.8 k flavonoids reveals novel insights into allosteric inhibition of SARS-CoV-2 M-PRO

dc.contributor.authorJimenez-Avalos, Gabriel
dc.contributor.authorPaula Vargas-Ruiz, A.
dc.contributor.authorDelgado-Pease, Nicolas E.
dc.contributor.authorOlivos-Ramirez, Gustavo E.
dc.contributor.authorSheen Cortavarria, Patricia
dc.contributor.authorFernandez-Diaz, Manolo
dc.contributor.authorQuiliano, Miguel
dc.contributor.authorZimic-Peralta, Mirko Juan
dc.contributor.authorCOVID-19 Working Grp Peru
dc.date.accessioned2021-10-04T23:00:56Z
dc.date.available2021-10-04T23:00:56Z
dc.date.issued2021
dc.description.abstractSARS-CoV-2 main protease is a common target for inhibition assays due to its high conservation among coronaviruses. Since flavonoids show antiviral activity, several in silico works have proposed them as potential SARS-CoV-2 main protease inhibitors. Nonetheless, there is reason to doubt certain results given the lack of consideration for flavonoid promiscuity or main protease plasticity, usage of short library sizes, absence of control molecules and/or the limitation of the methodology to a single target site. Here, we report a virtual screening study where dorsilurin E, euchrenone a11, sanggenol O and CHEMBL2171598 are proposed to inhibit main protease through different pathways. Remarkably, novel structural mechanisms were observed after sanggenol O and CHEMBL2171598 bound to experimentally proven allosteric sites. The former drastically affected the active site, while the latter triggered a hinge movement which has been previously reported for an inactive SARS-CoV main protease mutant. The use of a curated database of 4.8 k flavonoids, combining two well-known docking software (AutoDock Vina and AutoDock4.2), molecular dynamics and MMPBSA, guaranteed an adequate analysis and robust interpretation. These criteria can be considered for future screening campaigns against SARS-CoV-2 main proteaseen_US
dc.description.sponsorshipEste trabajo fue financiado por CONCYTEC [número de contrato 048-2020].es_PE
dc.identifier.doihttps://doi.org/10.1038/s41598-021-94951-6
dc.identifier.urihttps://hdl.handle.net/20.500.12866/9801
dc.language.isoeng
dc.publisherSpringer Nature
dc.relation.ispartofurn:issn:2045-2322
dc.relation.ispartofseriesScientific Reports
dc.relation.issn2045-2322
dc.rightshttps://purl.org/coar/access_right/c_16ec
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subjectComputational biology and bioinformaticsen_US
dc.subjectDrug discoveryen_US
dc.subjectStructural biologyen_US
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.03.02
dc.titleComprehensive virtual screening of 4.8 k flavonoids reveals novel insights into allosteric inhibition of SARS-CoV-2 M-PROen_US
dc.typehttp://purl.org/coar/resource_type/c_6501
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dspace.entity.typePublication

Archivos